BENZYL-[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYL-ASPARTYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-SARCOSINATE-TRIESTER;COMPOUN
Compound with spectra: 1 NMR
![BENZYL-[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYL-ASPARTYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-SARCOSINATE-TRIESTER;COMPOUN](/api/compound/9mQl5oISro8.png?ph=true&h=300&w=458 "BENZYL-[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYL-ASPARTYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-SARCOSINATE-TRIESTER;COMPOUN")
| SpectraBase Compound ID | 9mQl5oISro8 |
|---|---|
| InChI | InChI=1S/C38H51N5O12/c1-38(2,3)55-37(51)42-29(36(50)53-6)22-31(45)41-28(21-25-13-9-7-10-14-25)34(48)39-20-19-30(44)40-27(35(49)52-5)17-18-32(46)43(4)23-33(47)54-24-26-15-11-8-12-16-26/h7-16,27-29H,17-24H2,1-6H3,(H,39,48)(H,40,44)(H,41,45)(H,42,51)/t27-,28+,29-/m1/s1 |
| InChIKey | UAVCCHXFWAFAKX-SSBOKUKZSA-N |
| Mol Weight | 769.8 g/mol |
| Molecular Formula | C38H51N5O12 |
| Exact Mass | 769.353422 g/mol |
| Enantiomer InChIKey | UAVCCHXFWAFAKX-NHKHRBQYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
BETA-BENZYL-(2S)-N-(TERT.-BUTOXYCARBONYL)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-SARCOSYL-[ALPHA-METHYL-(2R)-ASPARTATE]-TRIESTER
N-METHYL-(R)-2-[(R)-2-(METHYLOXY)-1-(TERT.-BUTOXYCARBONYLAMINO)-2-OXO-ETHYL]-5-PHENYLPENTANOYL-(S)-PHENYLALANINEAMIDE
TERT.-BUTYL-N-[(4R)-3-BENZYLOXYCARBONYL-5-OXOOXAZOLIDIN-4-YLACETYL]-(2S)-PHENYLALANINATE
BEAUVERIOLIDE-VII
(2R,3R/2S,3S)-DIBENZYL-1-[N-(TERT.-BUTOXYCARBONYL)-(S)-PHENYLALANYL]-AZIRIDINE-2,3-DICARBOXYLATE
SOLONAMIDE-A
L-Glutamic acid, N-[N-[N-[S-(2-methoxy-2-oxoethyl)-N-(trifluoroacetyl)-L-cysteinyl]-O-methyl-L-tyrosyl]-L-phenylalanyl]-, dimethyl ester
UNNARMICIN_A
(2R,3R)-DIETHYL-1-[N-(TERT.-BUTOXYCARBONYL)-(S)-PHENYLALANYL-(S)-ALANYL]-AZIRIDINE-2,3-DICARBOXYLATE
SCLERAMIDE
| Title | Journal or Book | Year |
|---|---|---|
| Design and preparation of serine–threonine protein phosphatase inhibitors based upon the nodularin and microcystin toxin structures: Part 1. Evaluation of key inhibitory features and synthesis of a rationally stripped-down nodularin macrocycle | Journal of the Chemical Society, Perkin Transactions 1 | 1997 |